Related Experiment Video
Updated: Apr 7, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Masked Uncontrolled Hypertension in CKD
Rajiv Agarwal1, Maria K Pappas2, Arjun D Sinha2
1Indiana University School of Medicine; Richard L. Roudebush Veterans Affairs Administration Medical Center, Indianapolis, Indiana ragarwal@iu.edu.
Insights
Masked uncontrolled hypertension (MUCH) is common in CKD patients, often missed in clinic. Ambulatory BP monitoring is reliable for diagnosis, especially when clinic BP is prehypertensive.
Area of Science:
- Nephrology
- Cardiology
- Hypertension Research
Background:
- Masked uncontrolled hypertension (MUCH) affects treated hypertensive patients who appear normotensive in clinic but are hypertensive outside.
- Chronic kidney disease (CKD) patients are a population where MUCH may be prevalent but underdiagnosed.
Purpose of the Study:
- To evaluate the prevalence and reproducibility of MUCH in veterans with CKD.
- To compare diagnostic accuracy between ambulatory BP monitoring (ABPM) and home BP monitoring (HBPM).
Main Methods:
- Prospective evaluation of 333 veterans with CKD using ABPM and HBPM.
- MUCH was defined using various ABPM (daytime, 24-hour, daytime/nighttime) and HBPM criteria.
- Reproducibility assessed by repeat measurements after 4 weeks.
Main Results:
- MUCH prevalence varied by definition: 26.7% (daytime ABPM) to 56.1% (daytime/nighttime ABPM).
- ABPM showed good reproducibility (κ=0.44-0.51), while HBPM had poor agreement (κ=0.25).
- MUCH prevalence increased with higher clinic systolic BP, with clinic BP predicting MUCH (AUC=0.82).
Conclusions:
- MUCH is common and reproducible in CKD patients.
- Ambulatory BP monitoring is the preferred method for confirming MUCH diagnosis.
- Suspect MUCH when clinic BP is in the prehypertensive range (120-139 mmHg).
Abstract:
Masked uncontrolled hypertension (MUCH) is diagnosed in patients treated for hypertension who are normotensive in the clinic but hypertensive outside. In this study of 333 veterans with CKD, we prospectively evaluated the prevalence of MUCH as determined by ambulatory BP monitoring using three definitions of hypertension (daytime hypertension ≥135/85 mmHg; either nighttime hypertension ≥120/70 mmHg or daytime hypertension; and 24-hour hypertension ≥130/80 mmHg) or by home BP monitoring (hypertension ≥135/85 mmHg). The prevalence of MUCH was 26.7% by daytime ambulatory BP, 32.8% by 24-hour ambulatory BP, 56.1% by daytime or night-time ambulatory BP, and 50.8% by home BP. To assess the reproducibility of the diagnosis, we repeated these measurements after 4 weeks. Agreement in MUCH diagnosis by ambulatory BP was 75-78% (κ coefficient for agreement, 0.44-0.51), depending on the definition used. In contrast, home BP showed an agreement of only 63% and a κ coefficient of 0.25. Prevalence of MUCH increased with increasing clinic systolic BP: 2% in the 90-110 mmHg group, 17% in the 110-119 mmHg group, 34% in the 120-129 mmHg group, and 66% in the 130-139 mmHg group. Clinic BP was a good determinant of MUCH (receiver operating characteristic area under the curve 0.82; 95% confidence interval 0.76-0.87). In diagnosing MUCH, home BP was not different from clinic BP. In conclusion, among people with CKD, MUCH is common and reproducible, and should be suspected when clinic BP is in the prehypertensive range. Confirmation of MUCH diagnosis should rely on ambulatory BP monitoring.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Antihypertensive Drugs: Potassium-Sparing Diuretics

